Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

223
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
223
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conductivity optimization of La<sub>0.3</sub>Sr<sub>0.7</sub>TiO<sub>3</sub>/La<sub>0.8</sub>Sr<sub>0.2</sub>MnO<sub>3</sub> bilayer interconnects <i>via</i> interfacial oxygen partial pressure regulation and its application in FT-SIS-SOFCs.

Chemical science·2026
Same author

[Effect of acupoint injection on olfactory dysfunction and apoptosis of olfactory mucosal cells in rats with allergic rhinitis].

Zhen ci yan jiu = Acupuncture research·2026
Same author

Skeletal Editing of 4-Substituted Isothiazoles to Pyrazoles Via a Two-Atom N-S to N-N Swap.

Organic letters·2026
Same author

["Yingxiang" (LI2) acupoint injection alleviates nasal allergy symptoms in allergic rhinitis rats by regulating Treg/Th17 immune balance].

Zhen ci yan jiu = Acupuncture research·2026
Same author

Photochemical Synthesis of DNA-Encoded 3<i>H</i>-Azepines via Skeletal Editing of Nitroarenes.

Organic letters·2026
Same author

MgO-MgAl<sub>2</sub>O<sub>4</sub>-Supported Flat-Tubular Segmented-In-Series SOFCs Featuring Ultra-High Conductivity Interlayer for Enhanced Performance.

ACS applied materials & interfaces·2026

Related Experiment Video

Updated: May 16, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.2K

Pt(IV)-PROTAC Complexes with Synergistic Antitumor Activity and Enhanced Membrane Permeability.

Cheng-Xin Li1,2, Zhi-Ru Zou1,2, Shan Xu1,2

  • 1State Key Laboratory of Anti-Infective Drug Discovery and Development, Sun Yat-sen University, Guangzhou 510006, China.

Journal of Medicinal Chemistry
|April 4, 2025
PubMed
Summary

New platinum-IV-PROTAC complexes induce DNA damage and inhibit DNA repair, showing potent anticancer activity. The compound CW-2 demonstrated significant antitumor effects in preclinical models, highlighting a promising therapeutic strategy.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.6K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.1K

Related Experiment Videos

Last Updated: May 16, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.2K
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.6K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.1K

Area of Science:

  • Medicinal Chemistry
  • Cancer Biology
  • Drug Discovery

Background:

  • Platinum-based chemotherapy remains a cornerstone in cancer treatment.
  • Developing novel platinum complexes with improved efficacy and reduced resistance is crucial.
  • Targeted drug delivery systems, like PROTACs, offer potential for enhanced cancer therapy.

Purpose of the Study:

  • To design and synthesize novel platinum(IV)-PROTAC complexes.
  • To evaluate their dual action in inducing DNA damage and inhibiting DNA repair.
  • To assess their antiproliferative and antitumor potential.

Main Methods:

  • Synthesis and characterization of Pt(IV)-PROTAC complexes.
  • In vitro antiproliferative assays against various cancer cell lines.
  • Assessment of intracellular platinum and PROTAC uptake.
  • Mechanistic studies including DNA damage, DNA repair inhibition, and apoptosis assays.
  • In vivo antitumor efficacy evaluation in a xenograft mouse model.

Main Results:

  • Novel Pt(IV)-PROTAC complexes were successfully synthesized.
  • These complexes exhibited significant antiproliferative activity against cancer cells.
  • Enhanced intracellular uptake of platinum and PROTAC components was observed.
  • Mechanisms involved DNA damage induction, DNA repair disruption, and apoptosis.
  • The compound CW-2 showed excellent in vivo antitumor activity.

Conclusions:

  • Pt(IV)-PROTAC complexes represent a promising new class of anticancer agents.
  • Their dual mechanism of action enhances therapeutic potential.
  • Further development of Pt(IV)-PROTACs could lead to novel antitumor therapeutics.